Ottobock Overview
- Year Founded
-
1919
- Status
-
Public
- Employees
-
9,454
- Stock Symbol
-
OBCK
- Investments
-
37
- Share Price
-
$42.12
- (As of Tuesday Closing)
Ottobock General Information
Description
Ottobock SE & Co KGaA is a medical technology company. It specializes in healthcare products and solutions designed to improve mobility and quality of life for people with disabilities or limited mobility. The company's portfolio includes prosthetics, orthotics, neuro-orthotics, rehabilitation products, wheelchairs, and bionic exoskeletons. The company manages its business activities through the operating segments EMEA (Europe, Middle East and Africa), Americas (North and South America) and APAC (Asia Pacific). The company develops, produces and distributes medical technology products and components in these regions and operates an extensive network of patient care facilities. The majority of revenue is derived from the EMEA segment.
Contact Information
Website
www.ottobock.comCorporate Office
- Max-Näder-Strasse 15
- 37115 Duderstadt
- Germany
Corporate Office
- Max-Näder-Strasse 15
- 37115 Duderstadt
- Germany
Ottobock Stock Performance
As of 17-Nov-2026, Ottobock’s stock price is $42.12. Its current market cap is $2.7B with 64M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $42.12 | $43.49 | $41.79 - $87.89 | $2.7B | 64M | 518.42 | $2.34 |
Ottobock Financials Summary
As of 30-Jun-2026, Ottobock has a trailing 12-month revenue of $2.02B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,854,115 | 6,258,599 | ||
| Revenue | 2,021,814 | 1,894,938 | 1,736,444 | 1,617,811 |
| EBITDA | 474,541 | 425,597 | 317,163 | 275,388 |
| Net Income | 150,015 | 101,746 | 32,679 | 53,022 |
| Total Assets | 2,576,763 | 2,407,499 | 2,102,476 | 2,195,877 |
| Total Debt | 1,391,150 | 1,234,642 | 1,253,681 | 1,312,441 |
Ottobock Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ottobock Comparisons
Industry
Financing
Details
Ottobock Competitors (32)
One of Ottobock’s 32 competitors is Meyra Group, a Private Equity-Backed company based in Porta Westfalica, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Meyra Group | Private Equity-Backed | Porta Westfalica, Germany | ||||
| Embla Medical | Corporation | Reykjavik, Iceland | ||||
| Inogen | Formerly VC-backed | Beverly, MA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Joerns Healthcare | Private Equity-Backed | Charlotte, NC |
Ottobock Patents
Ottobock Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102025119751-B3 | Orthopedic technical equipment | Active | 21-May-2025 | ||
| WO-2026229119-A1 | Prosthetic foot, foot cover, prosthetic foot insert and covering for a prosthetic foot, and method for assembling a prosthetic foot | Pending | 29-Apr-2025 | ||
| DE-102025116484-A1 | Prosthetic foot, foot shell, prosthetic foot insert and cover for a prosthetic foot and method for mounting a prosthetic foot | Pending | 29-Apr-2025 | ||
| DE-102025115162-A1 | Prosthetic joint | Pending | 17-Apr-2025 | ||
| WO-2026219657-A1 | Prosthetic joint | Pending | 17-Apr-2025 | A61F2/6607 |
Ottobock Signals
Ottobock Investments & Acquisitions (37)
Ottobock’s most recent deal was a Merger/Acquisition with Rehattiva. The deal was made on 01-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rehattiva | 01-Oct-2026 | Merger/Acquisition | Specialty Retail | ||
| Blue Arbor Technologies | 20-Jul-2026 | Early Stage VC | Therapeutic Devices | ||
| Fesia Technology | 07-Jul-2026 | Merger/Acquisition | Therapeutic Devices | ||
| Blatchford Norway | 13-May-2026 | Merger/Acquisition | Medical Supplies | ||
| Phantom Neuro | 21-Nov-2025 | Later Stage VC | Therapeutic Devices |
Ottobock ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Ottobock Affiliates
Subsidiaries (26)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Lindentor 1053. V V | Berlin, Germany | 2020 | |
| Romedis | Duderstadt, Germany | 2016 | |
| Fesia Technology | San Sebastian, Spain | 2016 | |
| Plus Medica OT | Dusseldorf, Germany | 2015 | |
| Otto Bock Healthcare Beteiligungen | Duderstadt, Germany | 2014 |
Ottobock FAQs
-
When was Ottobock founded?
Ottobock was founded in 1919.
-
Where is Ottobock headquartered?
Ottobock is headquartered in Duderstadt, Germany.
-
What is the size of Ottobock?
Ottobock has 9,454 total employees.
-
What industry is Ottobock in?
Ottobock’s primary industry is Therapeutic Devices.
-
Is Ottobock a private or public company?
Ottobock is a Public company.
-
What is Ottobock’s stock symbol?
The ticker symbol for Ottobock is OBCK.
-
What is the current stock price of Ottobock?
As of 17-Nov-2026 the stock price of Ottobock is $42.12.
-
What is the current market cap of Ottobock?
The current market capitalization of Ottobock is $2.7B.
-
What is Ottobock’s current revenue?
The trailing twelve month revenue for Ottobock is $2.02B.
-
Who are Ottobock’s competitors?
Meyra Group, Embla Medical, Inogen, Medtronic, and Joerns Healthcare are some of the 32 competitors of Ottobock.
-
What is Ottobock’s annual earnings per share (EPS)?
Ottobock’s EPS for 12 months was $2.34.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process